A carregar...

Targeting High Density Lipoproteins in the Prevention of Cardiovascular Disease?

Recent studies involving HDL-raising therapeutics have greatly changed our understanding of this field. Despite effectively raising HDL-C levels, niacin remains of uncertain clinical benefit. Synthetic niacin receptor agonists are unlikely to raise HDL-C or have other beneficial effects on plasma li...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Larach, Daniel, deGoma, Emil M., Rader, Daniel J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3517174/
https://ncbi.nlm.nih.gov/pubmed/22991041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11886-012-0317-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!